Journal
MICROCHIMICA ACTA
Volume 174, Issue 3-4, Pages 353-360Publisher
SPRINGER WIEN
DOI: 10.1007/s00604-011-0633-0
Keywords
Fluorescence; Levofloxacin; Moxifloxacin; Terbium; Colloidal silver nanoparticles
Categories
Funding
- Kyungpook National University
- Ministry of Education, Science and Technology [2009-0093819]
Ask authors/readers for more resources
We report on a fluorometric method for the determination of the fluoroquinolones levofloxacin (LEV) and moxifloxacin (MOXI). It is based on the Tb(III)-sensitized luminescence that is plasmonically enhanced by silver nanoparticles (Ag NPs). The emission of the Tb(III) complexes has maximum at 545 nm after excitation at 284 nm and is strongly enhanced in the presence of the colloidal Ag NPs. Under optimum experimental conditions, luminescence intensity increases linearly with the concentration in the range from 4.16 x 10(-17)-3.59 x 10(-15) M of LEV, and from 4.98 x 10(-17)-2.49 x 10(-15) M for MOXI with correlation coefficients of 0.9996 and 0.9996, respectively. The limits of detection are 7.19 x 10(-18) M and 8.47 x 10(-18) M, respectively, and the relative standard deviations are 1.3 and 1.5% for 5 replicate measurements at 6.08 x 10(-14) M of LEV and 5.48 x 10(-14) M of MOXI. The method was successfully applied to the determination of LEV and MOXI in pharmaceutical samples, in urine and in serum.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available